Friday 6 November 2026 Export SHC’s income statement to Excel — free account

Sotera Health Company

SHC Healthcare Diagnostics & Research

Sotera Health Company’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.74% from fiscal 2024.

Revenue: +4.36%
EPS: +20.1%
Free cash flow: +65.0%
Total debt: +0.14%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

15.72 0.15 −0.95%

Follow SHC

Alert me

Market cap: $4.5B
P/E: 26.3×
Fwd P/E: 26.4×
Dividend yield: —
F-score: 7/9
Altman Z: 1.76
Beneish M: −2.75
Dividend safety: n/a

Overview

Sotera Health Company (SHC) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Sotera Health Company (SHC) trades at a P/S ratio of 3.7×. Over the past ten years it has ranged from 1.7× (November 2022) to 9.0× (March 2021); the current reading is higher than 27% of that period. That is below the Diagnostics & Research industry median of 4.2× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/SHC/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Sotera Health Company P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/SHC/metrics/ps-ratio">Sotera Health Company (SHC) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	4.3×	22.45%
FY2024	3.5×	(21.63%)
FY2023	4.5×	92.97%
FY2022	2.3×	(67.07%)
FY2021	7.1×	(16.96%)
FY2020	8.5×	16.10%
FY2019	7.3×	0.00%
FY2018	7.3×	—

Period	P/S ratio	Change
Sep 2026	4.3×	3.10%
Jun 2026	4.2×	21.40%
Mar 2026	3.4×	(20.19%)
Dec 2025	4.3×	10.82%
24 more quarters	Free account

Against its own ten years

Low 1.7× High 9.0×

Ten-year median 4.3×

Current reading's percentile 27

Company	P/S ratio
RDNT RadNet, Inc. compare	2.7×
NEO NeoGenomics, Inc. compare	2.7×
VCYT Veracyte, Inc. compare	3.3×
SHC Sotera Health Company	3.7×
QGEN QIAGEN N.V. compare	5.0×
CDNA CareDx, Inc. compare	8.1×
BLLN BillionToOne, Inc. compare	12.1×
ADPT Adaptive Biotechnologies Corporation compare	14.5×
GRAL GRAIL, Inc. compare	34.9×
Diagnostics & Research industry median	4.2×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Sotera Health Company (SHC) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on SHC

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on SHC

Stockrow Weekly